Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Fast-growings companies in Carbonic anhydrase inhibitor
by Most Patent Filing In 5 Years in the United States in 2018

The Carbonic anhydrase inhibitor top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 5 Years Carbonic anhydrase inhibitor Fast-growings in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Carbonic anhydrase inhibitors are a class of pharmaceuticals that suppress the activity of carbonic anhydrase. Their clinical use has been established as anti-glaucoma agents, diuretics, antiepileptics, in the management of mountain sickness, gastric and duodenal ulcers, idiopathic intracranial hypertension, neurological disorders, or osteoporosis.
#
Company Name
Region
Tech Topics
Total
1
Medicine,Health care,Glaucoma,
...[+2]
Patent: 17
2
Medicine,Health care,Obesity,
...[+2]
Patent: 7
3
Primary care physician,Health care,Hospitality industry,
...[+2]
Patent: 6
4
Medicine,Health care,Drug,
...[+2]
Patent: 4
5
History of the United States,Bequest,Medicine,
...[+2]
Patent: 2
6
Health care,Library science,Medicine,
...[+2]
Patent: 1
7
Library science,Community engagement,Critical thinker,
...[+2]
Patent: 1
8
Patent: 1
9
Medicine,Health care,Biopharmaceutical,
...[+2]
Patent: 1
10
Journalism,Professional studies,Medicine,
...[+2]
Patent: 1
Page generation time: Apr 30 2025